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Abstract: We previously reported that trait aggression,
proposed as an endophenotype for suicidal behavior, is
positively associated with Toxoplasma gondii (T. gondii)
seropositivity in females, but not in males. Additionally,
older males seropositive for T. gondii had lower scores on
measures of trait aggression, including self-aggression.
Trait aggression may be influenced by dopaminergic
signaling, which is known to be moderated by gender
and age, and potentially enhanced in T. gondii positives
through the intrinsic production of dopamine by the
microorganism. Therefore, we investigated associations
between trait aggression and interactions between T. gondii enzyme-linked immunoabsorbant assay (ELISA) IgG
titer-determined seropositivity and high-performance liquid chromatography- (HPLC-) measured blood levels of
dopamine precursors phenylalanine (Phe), tyrosine (Tyr),
and their ratio in a sample of 1000 psychiatrically healthy
participants. Aggressive traits were assessed using the
questionnaire for measuring factors of aggression (FAF),
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the German version of the Buss-Durkee hostility questionnaire. We found that 1) the decrease in trait aggression
scores in T. gondii-positive older males was only present
in individuals with a low Phe:Tyr ratio, and 2) that there
was a positive correlation between Phe:Tyr ratio and total
aggression and selected subscales of aggression in T.
gondii-positive males, but not in T. gondii-negative males.
These findings point toward a gender-specific reciprocal
moderation by Phe:Tyr ratio and T. gondii seropositivity
of their associations with aggression scores, and lead to
experimental interventions geared to manipulating levels
of dopamine precursors in selected T. gondii positive individuals with increased propensity for aggression.
Keywords: aggressive personality traits; phenylalanine;
seropositivity; Toxoplasma gondii; tyrosine.

Introduction
We previously reported [1] that trait aggression, proposed as
an endophenotype for suicidal behavior, is positively associated with Toxoplasma gondii seropositivity in females, but
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not in males. Converging lines of evidence have catalyzed
an interest in the link between inflammation and mental
illness [2, 3]. While elevated proinflammatory cytokines
and glial cell abnormalities represent trait markers of major
mental illnesses like major depressive disorder [4, 5], bipolar
disorder [5, 6] and schizophrenia [5, 7], there also appears to
be a state-mediated effect of suicidal behavior [8–10], acuity
of mood episode or psychosis [6, 11, 12] and treatment [11–14]
on cytokine levels, microglial activation and other indicators
of central inflammation. Trait aggression [15–18] and impulsivity [19, 20], behaviors often present in these illnesses, are
also associated with elevations of inflammatory biomarkers
as suggested by human [21–25] and animal studies [26–29].
Higher rates of latent infection with neurotropic pathogens
like Toxoplasma gondii (T. gondii) and Herpesvidae family
viruses [30–34], may contribute to the low-grade immune
activation observed in these conditions. Latent toxoplasmosis, during which only bradyzoites (tissue cysts) are present,
previously considered harmless, is linked to major psychiatric illnesses [30, 31, 33] as well as suicidal behavior [35–41].
We recently reported, in psychiatrically healthy
individuals, that trait aggression, proposed as an
endophenotype for suicide [42–44], was associated with
T. gondii seropositivity [1] in females but not in males. We
also noted that males over the age of 60 who were seropositive for T. gondii had significantly lower scores on measures of trait aggression including self-aggression. This is
consistent with previous reports that the differences in
personality measures associated with T. gondii seropositivity are sex-specific [45, 46]. Sex-specific differences in
personality dimensions in relationship to T. gondii have
been described in the past in subjects in whom mental
illness was not ruled out in a systematic manner [47–50].
The associations between trait measures like aggression
and T. gondii seropositivity may be mediated by dopaminergic neurotransmission. Previous studies have demonstrated an increase in dopamine synthesis and release, as
well as elevated homovanillic acid (HVA), a metabolite of
dopamine, in T. gondii-infected neurons in animals [51–54].
Additionally, anti-dopaminergic agents prevent behavioral
alterations induced by T. gondii in animals [55, 56]. Of potential high relevance, two genes encoding tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis, were
identified in the genome of T. gondii [57]. Toxoplasma gondii
and its influence on dopamine signaling is also suggested
by a decrease in the psychobiological construct of noveltyseeking, one of the temperaments in the Temperament and
Character Inventory (TCI) related to dopamine [58], in association with T. gondii seropositivity in humans [45, 59, 60].
Dopaminergic neurotransmission has also been implicated in the neurobiology of aggression [61–64]. Genetic

polymorphisms involved in altered dopamine receptor
and transporter activities as well as enzymes involved in
the metabolism of dopamine have been identified in association with aggression in humans and animals [65, 66].
The direction of the relationship between dopamine and
aggression is far from unequivocal. Some studies have
reported a positive relationship between dopaminergic
neurotransmission and aggression [67, 68], while others
point to a dopaminergic deficit in the relationship with
aggression, in particular impulsive aggression [64, 65, 69,
70]. These conflicting findings may be due in part to both
context dependency of the relationship between dopamine
and aggression, and genetic influences, such as functional
allelic variants of monoamine oxidase A, which metabolizes dopamine [71].
Conversion of phenylalanine, an essential amino acid,
to tyrosine via the activity of phenylalanine hydroxylase
(PAH), is the first step towards the synthesis of dopamine.
Tyrosine is further converted into dopamine via a two-step
enzymatic reaction involving tyrosine hydroxylase (ratelimiting enzyme in the biosynthesis of catecholamines)
and aromatic L-type amino acid decarboxylase [72, 73].
Type 1 T-helper cell immunity (Th1), which acts against
intracellular pathogens like T. gondii [74], is linked to dysfunction of PAH, and subsequently, an elevated Phe:Tyr
ratio [75, 76]. This is thought to be mediated by oxidative
stress and reactive oxygen species- (ROS-) induced depletion of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4), an
essential cofactor for PAH [77, 78]. The ratio between phenylalanine and tyrosine (Phe:Tyr) provides an estimate of
PAH activity [78] and is elevated in proinflammatory conditions like cancer [79], trauma, sepsis [80], human immunodeficiency virus (HIV) infection [81] as well as depression
[76, 82] and schizophrenia [83–85]. Additionally, children
with phenylketonuria, a congenital decrease in activity
of PAH leading to elevated phenylalanine levels, exhibit
higher levels of aggression [86], with a positive correlation
between aggression ratings and phenylalanine levels [87].
In this add-on project, we sought to investigate
interactions among Phe, Tyr, and their ratio, T. gondii
seropositivity, and aggression measures in a sample of
psychiatrically healthy participants.

Materials and methods
Sample
This is an add-on study to a previous protocol on the genetics of mental illness. As a component of the “parent” protocol, 1000 healthy
adults were recruited from the Munich area in Germany. All the healthy
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controls provided written informed consent to take part in the parent
study after the study procedures were explained in detail. The local
Ethics Committee of Ludwig Maximilians University, Munich, Germany, approved the study, and the University of Maryland Institutional
Review Board (IRB) granted an exempt status considering that the data
were deidentified and recontacting participants in the future was rendered impossible. Axis I or II diagnoses were ruled out by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental
Disorders 4th Edition Text Revision (DSM-IV TR) [88]. History of suicide
attempts was also ruled out. Mental illness and suicidal behavior were
ruled out in first degree-relatives as well. Blood samples were drawn
without observing any fasting protocols or dietary restrictions from a
forearm vein into ethylenediaminetetraacetic acid (EDTA)-containing
tubes. Plasma obtained after centrifuging the sample for 10 min at 4°C
was aliquoted into Eppendorf tubes and frozen immediately at −80°C
and stored at this temperature until analysis of plasma Phe and Tyr.

between T. gondii seropositive and seronegative individuals. Then
subjects were stratified further based on age and sex to detect differences in aggression scores between seropositive and seronegative
individuals. Phe:Tyr ratio was converted into a categorical variable
by assigning all individuals with a ratio in the upper quartile as high
and all individuals with a ratio in the lower three quartiles as low, a
quartile-to-binary threshold we applied to monoamine precursors in
our previous work [92].
Further analysis by stratification based on high vs. low ratio was
performed.
Adjusted linear regression models, accounting for body mass
index (BMI), age, education level and sex were then used to determine if Phe or Tyr levels or the Phe:Tyr ratio were related to specific
subscales of aggression. All models were stratified by sex due to
previous evidence of sex-dependent shifts in personality traits by
T. gondii status.

Measurement of plasma phenylalanine and tyrosine

Results

Using high performance liquid chromatography (HPLC), plasma
phenylalanine and tyrosine levels were measured using 3-nitro-Ltyrosine as an internal standard as described elsewhere [84, 89].

Toxoplasma gondii serological analysis
Solid phase enzyme-linked immunosorbent assay (ELISA) was used to
measure immunoglobulin G (IgG) to T. gondii [35] (T. gondii IgG ELISA,
IBL Laboratories, Hamburg, Germany). After exposing diluted serum
to immobilized T. gondii antigens on the wells of microtiter plates,
specific antibodies binding to the antigen-coated wells were detected
using a human IgG-specific secondary enzyme-conjugated antibody.
Serointensity was determined by quantitative measurement of antibodies after substrate reaction, using optical density ratios between
the blood sample and a standard containing 10 international units of
anti-T. gondii antibody. A titer ≥ 0.8 was used to define seropositivity.
All T. gondii antibody measurements were performed at the Stanley
Laboratory of Developmental Neurovirology, Baltimore, MD and the
technician was blind to the study hypothesis.

Measures of aggression
Questionnaire for measuring factors of aggression (FAF-Fragebogen
zur Erfassung von Aggressivitätsfaktoren), a German version of the
Buss-Durkee hostility questionnaire [90, 91], was used to assess traitaggression in all participants. FAF is a self-administered inventory consisting of 76 items, 66 of which explore five components of aggressive
behavior including FAF-self-aggression (11 items), FAF-total aggression (35 items) and its three component subscales: FAF-spontaneous
aggression (19 items); FAF-reactive aggression (13 items); FAF-irritability (13 items). FAF demonstrates good internal consistency and testretest reliability with Cronbach’s α-values range from 0.61 to 0.79 [90].

Statistical analysis
Analysis of covariance (ANCOVA) was used to determine differences in FAF-total aggression, its subscales and FAF-self aggression

Sample characteristics
Approximately half the sample (n = 476, 50.1%) of patients
were positive for T. gondii based on the criteria of seropositivity of IgG > 0.8 with higher seroprevalence among
older subjects (60%) vs. younger subjects (34%) based on
a median age split (Table 1). This seroprevalence pattern
is similar to previously published estimates of seroprevalence of T. gondii from Germany [34, 93]. Mean age of the
sample was 53.6 (±15.8) with T. gondii-positive participants
being significantly older (59.1 ± 12.5) when compared to
T. gondii-negative patients (48.1 ± 16.8). Close to half the
sample was university educated (45.8%) with T. gondiiseropositive patients having lower educational attainment
(p < 0.004). Mean Phe:Tyr ratio was significantly lower in
T. gondii-positive individuals when compared to T. gondiinegative individuals. BMI was higher in T. gondii-positive
vs. T. gondii-negative individuals.

Toxoplasma gondii seropositivity and trait
aggression
There were no differences in aggression scores between
seropositive and seronegative individuals. As previously
reported [1], upon stratification by sex, females who were
positive for T. gondii had higher FAF-reactive aggression
scores when compared to T. gondii-negative females
after adjustment for age, BMI and education [F(1480) = 4.1,
p = 0.04] but did not differ on any other scales of aggression including total aggression.
In males, T. gondii-seropositive individuals had
decreased scores on FAF-total aggression [F(1457) = 6.98,
p = 0.009], FAF-spontaneous aggression [F(1457) = 5.0,

80

Mathai et al.: Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine

Table 1: Characteristics of study sample (n = 950) by T. gondii status.
T. gondii IgG+a (n = 476)

T. gondii IgG− (n = 474)

Total (n = 950)

p-Valueb

59.1 ± 12.5

48.1 ± 16.8

53.6 ± 15.8

p < 0.001

243 (51.0)
233 (48.9)

220 (46.4)
254 (53.6)

463 (48.7)
487 (51.3)

p = 0.153

145 (30.5)
147 (30.9)
184 (38.6)
25.3 ± 4.0
0.734 ± 0.31

86 (18.1)
137 (28.9)
251 (53.0)
24.3 ± 3.7
0.821 ± 0.39

230 (24.3)
284 (29.9)
435 (45.8)
24.8 ± 3.9
0.803 ± 0.57

p < 0.001

Age, mean ± SD
Sex, n (%)
Male
Female
Education, n (%)
Primary
Secondary
University
BMIc, mean ± SD
Phe:Tyrd, mean ± SD

p < 0.001
p < 0.001

IgG, immunoglobulin G serum antibody status, tested by ELISA. aOptical density ratio between the blood sample and a standard containing
10 international units of anti-Toxoplasma gondii IgG ≥ 0.8. bStatistical tests using t-test for continuous and χ2-test for categorical variables.
c
BMI, body mass index (kg/m2). dPhe:Tyr, ratio between plasma phenylalanine and tyrosine levels.

p = 0.03], FAF-irritability F(1457) = 5.0, p = 0.03] and FAFself-aggression [F(1456) = 5.2, p = 0.03] when compared to T.
gondii-negative males after adjusting for age, BMI and education. On further stratification by age, this strong effect
was observed only in older males (≥ 60 years old) but not
in younger males [F(1274) = 10.5, p = 0.001]. Post hoc analysis
showed that the average difference between seropositive
and seronegative older males in FAF-total aggression was
2.5 points (CI = 1.1–4.0, p = 0.001). Similar observations of
lower aggression scores in seropositive males over the age
of 60 were observed with FAF-spontaneous aggression
[F(1274) = 6.2, p = 0.01]. FAF-reactive aggression [F(1274) = 6.4,
p = 0.01], FAF-irritability F(1274) = 9.2, p = 0.003), and FAFself-aggression [F(1273) = 9.0, p = 0.003].

High vs. low Phe:Tyr ratio
Upon further stratification by high vs. low Phe:Tyr
ratio, seropositive males over the age of 60 continued
to 
demonstrate decreased FAF-total aggression scores
[F(1198) = 8.7, p = 0.004] and FAF-self-aggression [F(1197) = 6.1,
p = 0.02] if the Phe:Tyr ratio was low, but no differences
were observed if the Phe:Tyr ratio was high (p-value was
0.24 and 0.90 respectively). This effect was also present for
the subscale scores of FAF-reactive aggression [F(1198) = 7.4,
p = 0.007] and FAF-irritability [F(1198) = 6.6, p = 0.01].

Associations between Phe, Tyr, Phe:Tyr ratio
and trait aggression score
There were no relationships detected between Phe, Tyr
or Phe:Tyr ratio and FAF-total aggression, self-aggression
or the subscale scores (reactive aggression, spontaneous

aggression and irritability) initially, after adjusting for
age, sex, BMI and education (Table 2). After stratifying by
T. gondii status and sex, there was a positive correlation
between FAF-total aggression/FAF-spontaneous aggression and Phe:Tyr ratio in T. gondii-seropositive males but
not in seronegative males.

Discussion
Our main findings were that; a) the decrease in trait aggression scores in T. gondii-positive older males and aggression was only present in individuals with low Phe:Tyr
ratio, with no significant association observed in subjects
with a high Phe:Tyr ratio, and b) that there was a positive
correlation between Phe:Tyr ratio and Total aggression
and selected subscales of aggression in T. gondii-positive
males but not in seronegative males. To our knowledge,
this is the first study reporting the moderating role by the
Phe:Tyr ratio of the association between T. gondii-seropositivity and trait aggression.
Our findings point to Phe:Tyr ratio moderating the
association between T. gondii-seropositivity and aggression in older males, with a lowering of aggression in
T. gondii-positives only present in those who have a lower
Phe:Tyr.
A higher Phe:Tyr ratio may lead to impedance in
dopaminergic neurotransmission, which may negate the
potentially dopamine-mediated protective link between
T. gondii and aggression in older males. Supporting this
hypothesis, decreased dopamine synthesis capacity in
the midbrain was linked with aggression in humans using
positron-emission tomography (PET) [64]. A negative
relationship between cerebrospinal fluid HVA levels, a
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Table 2: Associations of FAF total score and selected subscale scores with Phe:Tyr rank in T. gondii positive vs. T. gondii negative individuals
stratified by sex after adjustment for age, BMI and education.
T. gondii IgG+c

FAF scores

Total aggression
Male
Female
Total
Self-aggression
Male
Female
Total
Spontaneous aggression
Male
Female
Total
Reactive aggression
Male
Female
Total
Irritability
Male
Female
Total

T. gondii IgG–

Total

B

SE

p-Value

B

SE

p-Value

B

SE

p-Value

2.51
−1.5
0.02

1.12
1.17
0.81

0.026
0.2
0.9

0.55
−1.33
−0.07

1.23
0.79
0.73

0.6
0.09
0.9

1.23
−1.32
−0.019

0.83
0.68
0.54

0.1
0.06
0.9

0.77
0.31
0.46

0.39
0.36
0.26

0.050
0.4
0.09

−0.31
−0.22
−0.22

0.36
0.29
0.23

0.4
0.4
0.3

0.03
0.07
0.06

0.26
0.22
0.17

0.9
0.7
0.7

1.38
−0.83
0.024

0.47
0.51
0.35

0.004
0.1
0.95

0.46
−0.29
0.20

0.55
0.28
0.30

0.4
0.3
0.5

0.77
−0.50
0.14

0.36
0.28
0.23

0.04
0.08
0.5

1.00
0.28
0.54

0.5
0.42
0.32

0.046
0.5
0.09

0.20
−0.24
0.07

0.41
0.3
0.25

0.6
0.4
0.8

0.5
0.02
0.26

0.31
0.25
0.2

0.1
0.9
0.2

0.12
−0.98
−0.54

0.48
0.48
0.34

0.8
0.042
0.1

−0.11
−0.79
−0.34

0.44
0.43
0.30

0.8
0.07
0.3

−0.03
−0.85
−0.42

0.32
0.32
0.22

0.9
0.008
0.06

FAF, Fragebogen zur Erfassung von Aggressivitätsfaktoren (German adaptation of the Buss-Durkee hostility inventory); Phe:Tyr, ratio
between plasma phenylalanine and tyrosine; IgG, immunoglobulin G serum antibody status, tested by ELISA. aIndividual scale score differences are model-based estimates from linear regression model adjusted for age, education and BMI and stratified by sex/T. gondii status.
b
Total FAF score and selected FAF component score (self-aggression, spontaneous aggression, reactive aggression and irritability). cOptical
density ratio between the blood sample and a standard containing 10 international units of anti-Toxoplasma gondii IgG ≥ 0.8. Bold face
values denote statistically significant associations.

major metabolite of dopamine, and impulsive aggression
also points to decreased dopaminergic function [94] in
aggressive behaviors. Lower functioning dopamine receptor profiles were reported to predict aggressive responses
in an analysis of dopamine receptor polymorphisms and
their relationships to aggression [65]. Toxoplasma gondiiinfected dopaminergic neurons show an increase in intracellular dopamine in rodents [52]. In rodent-models, an
activation of dopamine-responsive sexual pathways, has
been described in T. gondii-infected rodents upon exposure to cat urine [95]. Moreover, T. gondii genome contains
two genes that code for tyrosine hydroxylase enzyme, one
of which is exclusively activated in the bradyzoite or tissue
cyst stage, which localizes to brain and muscle tissue in
latent toxoplasmosis [57].
Alternatively, Phe:Tyr ratio, a proxy for PAH activity, and thereby proinflammatory states [75], may also
reflect the moderation of aggression by inflammation
in T. gondii-positive individuals. Patients with intermittent explosive disorder (IED), a psychiatric condition,
with recurrent impulsive aggression, have been reported
to manifest elevated blood markers of inflammation like

C-reactive protein (CRP) and interleukin (IL)-6 [23, 24],
and very recently, increased rates of T. gondii seropositivity [96]. Moreover, in these patients with “rage” traits, and
documented episodes of aggression, the aggression scores
were higher in T. gondii-positive individuals. Our findings
of a positive correlation between aggression and Phe:Tyr
in T. gondii-positive males may lend credence to the possibility of low grade inflammation, triggered and perpetuated by the parasitic infection, leads to aggression either
directly, or, in part, through a higher Phe:Tyr ratio.
Sex-specific differences in personality profile with
regards to T. gondii have been described in the past and
our results suggest that the correlations between Phe:Tyr
ratio and aggression are specific to male subjects positive
for T. gondii. We have previously reported age- and sexdependent differences in trait aggression and impulsivity in T. gondii-positive individuals, with higher reactive
aggression in T. gondii positive females and higher impulsivity in T. gondii-positive young males [1]. Despite the
possibility of correlations among personality factors that
overlap and co-vary by sex, animal studies point to the parasite inducing sex-specific changes in neurotransmitter
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activity [97], mating behavior [49, 98, 99] and production
of sex hormones [100].
One of the limitations of the study is that we did not
obtain fasting levels of Phe and Tyr as there is evidence
for heterogeneity in plasma levels of amino acids based
on timing of meals and dietary preferences [101]. Moreover, the cross-sectional nature of the study precludes
estimating causal relationships between dopamine precursors and aggression in T. gondii-positive individuals.
The effect of stress and the influence of stress-related hormones were not analyzed, thus not statistically accounting for these potentially relevant confounders. We did not
correct the level of significance for multiple comparisons,
and thus our results and interpretation are prone to Type I
error. Yet, we position our study as, primarily, hypothesis
generating rather than testing, leading to future hypothesis testing study designs. Direct markers of immune
response like cytokines and acute phase reactants were
not measured due to the insufficient volume of plasma
samples, considering that this was an add-on study. Additionally, we only used self-report questionnaires instead
of observed aggressive events, or collateral informants.
For all the above reasons, the results of this study must be
considered preliminary and, thus, requiring replication.
Despite these limitations, our study had several
strengths; we studied a large sample of normal individuals without any overt psychopathology, family history of
mental illness suicidal behavior or substance use [1]. The
majority of studies exploring the relationship between
personality and T. gondii involved subjects in whom
mental illnesses was not ruled out using a structured and
validated tool [45, 47, 49, 59, 60]. This previous approach
runs the risk of spurious associations between T. gondii
seropositivity and personality changes, as they may be
confounded by unmeasured mental illness. This study
supports the possibility that aggressive traits are directly
linked to T. gondii seropositivity, and not as a mere byproduct of the established link between mental illness, and
implicitly, its treatment, and T. gondii infection [30, 33].
These findings, as was the case in our previous work [1],
persisted after post-hoc controlling for cytomegalovirus
(CMV) and herpes simplex virus 1 (HSV1) titers and were
independent of CMV/HSV1 seropositivity (for methodology see our previous article Cook et al. (2015) [1].
In conclusion, if replicated and confirmed by further
longitudinal and, ideally, experimental designs, our findings may pave the way for individualized interventions
geared towards optimizing blood levels of dopamine
precursors in T. gondii-positive individuals with aggressive personality traits, and in particular those with overt
history of aggression and suicidal behavior.
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